Exponent (NASDAQ:EXPO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Key Points

• Exponent beat quarterly estimates: The company reported EPS of $0.64, exceeding the $0.60 consensus, while revenue reached $173.73 million versus expectations of $149.64 million.
• Shares rose to $78.31 following the results, near the stock’s 52-week high of $81.95. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $81.00.
• CEO Catherine Corrigan sold 1,707 shares for approximately $113,140 under a pre-arranged Rule 10b5-1 trading plan; insiders own 1.70% of the company.

Exponent (NASDAQ:EXPO - Get Free Report) announced its earnings results on Thursday. The business services provider reported $0.64 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.60 by $0.04, FiscalAI reports. Exponent had a return on equity of 31.48% and a net margin of 17.67%. The company had revenue of $173.73 million for the quarter, compared to analyst estimates of $149.64 million.

Exponent Stock Performance

Shares of NASDAQ EXPO traded up $1.20 during midday trading on Thursday, hitting $78.31. The company's stock had a trading volume of 874,111 shares, compared to its average volume of 516,754. Exponent has a 1-year low of $51.91 and a 1-year high of $81.95. The firm's fifty day moving average price is $69.81 and its 200-day moving average price is $66.59. The firm has a market cap of $3.72 billion, a P/E ratio of 35.12 and a beta of 0.69.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on EXPO. UBS Group set a $72.00 price target on shares of Exponent and gave the company a "neutral" rating in a report on Friday, July 31st. JPMorgan Chase & Co. boosted their price objective on Exponent from $80.00 to $90.00 and gave the company an "overweight" rating in a report on Friday, July 31st. Finally, Weiss Ratings upgraded Exponent from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, October 9th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $81.00.

Insider Transactions at Exponent

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the transaction, the chief executive officer owned 129,108 shares of the company's stock, valued at $8,557,278.24. This trade represents a 1.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by corporate insiders.

About Exponent

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.